diclofenac and 8-epi-prostaglandin f2alpha

diclofenac has been researched along with 8-epi-prostaglandin f2alpha in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klein, T; Neuhaus, K; Nüsing, RM; Reutter, F1
Camici, G; Fiedler, M; Fratton, A; Gay, RE; Gay, S; Hellermann, JP; Hermann, M; Hurlimann, D; Lüscher, TF; Neidhart, M; Ruschitzka, F; Tanner, FC; Thiery, J1
Aita, T; Ishihata, A; Katano, Y; Ogaki, T1
Brunner, M; Burian, A; Burian, B; Crevenna, R; Frangione, V; Keilani, M; Leuratti, C; Mautone, G; Rovati, S; Vaccani, A; Zeitlinger, M1

Trials

1 trial(s) available for diclofenac and 8-epi-prostaglandin f2alpha

ArticleYear
An exploratory microdialysis study investigating the effect of repeated application of a diclofenac epolamine medicated plaster on prostaglandin concentrations in skeletal muscle after standardized physical exercise.
    British journal of clinical pharmacology, 2013, Volume: 76, Issue:6

    Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Exercise; Healthy Volunteers; Humans; Male; Microdialysis; Quadriceps Muscle; Transdermal Patch; Young Adult

2013

Other Studies

3 other study(ies) available for diclofenac and 8-epi-prostaglandin f2alpha

ArticleYear
Generation of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanism.
    British journal of pharmacology, 2001, Volume: 133, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arachidonic Acid; Blotting, Western; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dexamethasone; Diclofenac; Dinoprost; Dose-Response Relationship, Drug; Epoprostenol; Esters; F2-Isoprostanes; Female; Free Radicals; In Vitro Techniques; Isoenzymes; Kidney Glomerulus; Male; Membrane Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Sulfonamides; Thromboxane-A Synthase

2001
Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.
    Circulation, 2003, Nov-11, Volume: 108, Issue:19

    Topics: Acetylcholine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dinoprost; Endothelium, Vascular; Enzyme Inhibitors; F2-Isoprostanes; Hypertension; Interleukin-1; Isoenzymes; Lactones; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Inbred Dahl; Safety; Sodium Chloride, Dietary; Sulfonamides; Sulfones; Vasodilation

2003
Role of prostaglandins in urotensin II-induced vasodilatation in the coronary arteries of aged rats.
    European journal of pharmacology, 2005, Oct-31, Volume: 523, Issue:1-3

    Topics: Aging; Analysis of Variance; Animals; Coronary Circulation; Coronary Vessels; Cyclooxygenase Inhibitors; Diclofenac; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; In Vitro Techniques; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Inbred F344; Time Factors; Urotensins; Vasodilation; Vasodilator Agents

2005